[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_9352",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_9352"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB09265"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "adlyxin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus adlyxin is a glucagon like peptide 1 glp 1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus 1 limitations of use 1 has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis consider other antidiabetic therapies in patients with a history of pancreatitis not for treatment of type 1 diabetes or diabetic ketoacidosis has not been studied in combination with short acting insulin has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis limitations of use adlyxin has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis consider other antidiabetic therapies in patients with a history of pancreatitis see warnings and precautions 5 2 adlyxin is not a substitute for insulin adlyxin is not indicated for use in patients with type 1 diabetes mellitus or for treatment of diabetic ketoacidosis the concurrent use of adlyxin with short acting insulin has not been studied and is not recommended adlyxin has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis"
    } ],
    "https://w3id.org/biolink/vocab/association_type" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/TreatmentIndication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB09265",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-07-03T14:40:18.947+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "Msk+Jx9xoiZCmiVzTmCkoc9R3Bdc7yLFJrrflF7Zq9JyHSlazXOz/AUj64hCqv0+VHKkU6AMbhgdxKdd6dE2zNLWIbH5O+Y31KjBaEMUz13y0uu78RIEFCx4OibXuPXNXp1QPgF/M81gnjZuYHlU9RcmsPewq4I4uQfw+bgGxiA="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#pubinfo"
} ]